Geneos Wealth Management’s Carlisle Companies CSL Stock Holding History

Geneos Wealth Management’s Portfolio CSL Stock Details CSL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$264K	Buy	819 +69	+9%	+$24K	0.01%	983
2026 Q2	$272K	Hold	750	–	–	0.01%	897
2026 Q1	$250K	Hold	750	–	–	0.01%	890
2025 Q4	$240K	Hold	750	–	–	0.01%	871
2025 Q3	$247K	Sell	750 -99	-12%	-$37.7K	0.01%	841
2025 Q2	$317K	Buy	849 +510	+150%	+$189K	0.01%	844
2025 Q1	$115K	Buy	339 +84	+33%	+$30.1K	﹤0.01%	1105
2024 Q4	$94.1K	Buy	255 +1	+0.4%	+$436	﹤0.01%	1089
2024 Q3	$114K	Buy	254 +4	+2%	+$1.66K	﹤0.01%	929
2024 Q2	$101K	Hold	250	–	–	﹤0.01%	866
2024 Q1	$98K	Hold	250	–	–	﹤0.01%	855
2023 Q4	$78.1K	Hold	250	–	–	﹤0.01%	913
2023 Q3	$64.8K	Hold	250	–	–	﹤0.01%	1002
2023 Q2	$64.1K	Hold	250	–	–	﹤0.01%	1006
2023 Q1	$56.5K	Hold	250	–	–	﹤0.01%	1033
2022 Q4	$58.9K	Hold	250	–	–	﹤0.01%	995
2022 Q3	$70K	Hold	250	–	–	﹤0.01%	918
2022 Q2	$60K	Hold	250	–	–	﹤0.01%	1199
2022 Q1	$61K	Hold	250	–	–	﹤0.01%	1290
2021 Q4	$62K	Sell	250 -281	-53%	-$64.5K	﹤0.01%	1378
2021 Q3	$107K	Hold	531	–	–	﹤0.01%	1149
2021 Q2	$101K	Sell	531 -176	-25%	-$32.7K	﹤0.01%	1157
2021 Q1	$135K	Hold	707	–	–	﹤0.01%	1156
2020 Q4	$88K	Buy	707 +457	+183%	+$64.2K	﹤0.01%	1195
2020 Q3	$29K	Hold	250	–	–	﹤0.01%	1478
2020 Q2	$29K	Hold	250	–	–	﹤0.01%	1453
2020 Q1	$29K	Sell	250 -150	-38%	-$22.3K	﹤0.01%	1354
2019 Q4	$65K	Hold	400	–	–	﹤0.01%	1129
2019 Q3	$57K	Sell	400 -66	-14%	-$9.27K	﹤0.01%	1118
2019 Q2	$65K	Hold	466	–	–	﹤0.01%	1072
2019 Q1	$57K	Sell	466 -77	-14%	-$8.89K	﹤0.01%	1080
2018 Q4	$53K	Sell	543 -345	-39%	-$35.5K	﹤0.01%	1063
2018 Q3	$108K	Buy	888 +188	+27%	+$23K	0.01%	854
2018 Q2	$75K	Hold	700	–	–	0.01%	882
2018 Q1	$73K	Hold	700	–	–	0.01%	853
2017 Q4	$79K	Hold	700	–	–	0.01%	822
2017 Q3	$70K	Hold	700	–	–	0.01%	825
2017 Q2	$66K	Hold	700	–	–	0.01%	827
2017 Q1	$74K	Sell	700 -35	-5%	-$3.75K	0.01%	752
2016 Q4	$81K	Hold	735	–	–	0.01%	672
2016 Q3	$75K	Buy	735 +35	+5%	+$3.65K	0.01%	671
2016 Q2	$73K	Hold	700	–	–	0.01%	681
2016 Q1	$69K	Buy	+700	New	+$61.7K	0.01%	690

Other funds holding CSL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $5.55B AUM 53.94% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Geneos Wealth Management's CSL Position: Q3 2026 in Review

Geneos Wealth Management increased its Carlisle Companies (CSL) stake by 9.2% in Q3 2026, buying an estimated $24K and bringing the position to 819 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #983.

Geneos Wealth Management first reported a position in CSL in Q1 2016 and has held it in 43 quarters since. The position peaked at $317K in Q2 2025. 385 funds tracked by Wall St. Rank hold CSL as of Q3 2026.

Geneos Wealth Management held 819 shares of Carlisle Companies worth $264K as of Q3 2026.
Geneos Wealth Management bought 69 Carlisle Companies shares in Q3 2026, an estimated $24K.
Carlisle Companies made up 0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #983 holding.
Geneos Wealth Management first reported a position in Carlisle Companies in Q1 2016 and has held it in 43 quarters since.
Geneos Wealth Management's Carlisle Companies position peaked at $317K in Q2 2025.
385 funds tracked by Wall St. Rank held Carlisle Companies as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.